Search This Blog

Wednesday, April 1, 2026

Cyclerion to merge with Korsana Biosciences in all-stock deal

 

 shareholders to own about 1.5% of combined company

  • Transaction supported by approximately $380 million in new investor commitments to the combined company.
  • Combined company will be renamed Korsana Biosciences and is expected to trade on Nasdaq under ticker “KRSA.”
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)